Aprea Therapeutics APRE Slips 4 as Stock Nears Critical 085 Support Level Biotech Stock Potential in Healthcare Key Considerations for Investors M Q1 2026 Earnings EPS Beat Drives Stock Higher Hegseth Praises Asian Allies for BurdenSharing and Warns Against Chinas Regional Influence